Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?

References

1. 1.↵
   1. Cheronov M,
   2. Hayashi M,
   3. Izawa M,
   4. et al

   . Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multivoxel proton MRS. Minim Invasive Neurosurg 2005;48:228–34

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Graves EE,
   2. Nelson SJ,
   3. Vigneron DB,
   4. et al

   . Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 2001;22:613–24

   Abstract/FREE Full Text
3. 3.↵
   1. Kumar AJ,
   2. Leeds NE,
   3. Fuller GN,
   4. et al

   . Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377–84

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Jain R,
   2. Narang J,
   3. Sundgren PM,
   4. et al

   . Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 2010;100:17–29.Epub 2010 Feb 24

   CrossRefPubMed
5. 5.↵
   1. Langleben DD,
   2. Segall GM

   . PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000;41:1861–67

   Abstract/FREE Full Text
6. 6.↵
   1. Covarrubias DJ,
   2. Rosen BR,
   3. Lev H

   . Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9:528–37

   Abstract/FREE Full Text
7. 7.↵
   1. Jain R,
   2. Scarpace L,
   3. Ellika S,
   4. et al

   . First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 2007;61:778–86

   PubMedWeb of Science
8. 8.↵
   1. Cha S,
   2. Lupo JM,
   3. Chen MH,
   4. et al

   . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078–84

   Abstract/FREE Full Text
9. 9.↵
   1. Hu LS,
   2. Baxter LC,
   3. Smith KA,
   4. et al

   . Relative cerebral blood volume values to differentiate high-grade glioma recurrence from post treatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009;30:552–58

   Abstract/FREE Full Text
10. 10.↵
    1. Ellika SK,
    2. Jain R,
    3. Patel SC,
    4. et al

    . Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol 2007;28:1981–87

    Abstract/FREE Full Text
11. 11.↵
    1. Law M,
    2. Yang S,
    3. Babb JS,
    4. et al

    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
12. 12.↵
    1. Sorensen AG,
    2. Batchelor TT,
    3. Zhang WT,
    4. et al

    . A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Res 2009;69:5296–300.Epub 2009 Jun 23

    Abstract/FREE Full Text
13. 13.↵
    1. Barajas RF Jr.,
    2. Chang JS,
    3. Segal MR,
    4. et al

    . Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009;253:486–96

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Hazle JD,
    2. Jackson EF,
    3. Schomer DF,
    4. et al

    . Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging 1997;7:1084–93

    PubMedWeb of Science
15. 15.↵
    1. Jain R,
    2. Ellika SK,
    3. Scarpace L,
    4. et al

    . Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol 2008;29:694–700

    Abstract/FREE Full Text
16. 16.↵
    1. Hopewell JW,
    2. Wright EA

    . The nature of latent cerebral irradiation damage and its modification by hypertension. Br J Radiol 1970;43:161–67

    Abstract/FREE Full Text
17. 17.↵
    1. Zhao W,
    2. Diz DI,
    3. Robbins ME

    . Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007;80:S23–31

    Abstract/FREE Full Text
18. 18.↵
    1. Lundqvist H,
    2. Rosander K,
    3. Lomanov M,
    4. et al

    . Permeability of the blood-brain barrier in the rat after local proton irradiation. Acta Radiol Oncol 1982;21:267–71

    CrossRefPubMed
19. 19.↵
    1. Remler MP,
    2. Marcussen WH

    . Time course of early delayed blood-brain barrier changes in individual cats after ionizing radiation. Exp Neurol 1981;73:310–14

    CrossRefPubMed
20. 20.↵
    1. Remler MP,
    2. Marcussen WH,
    3. Tiller-Borsich J

    . The late effects of radiation on the blood brain barrier. Int J Radiat Oncol Biol Phys 1986;12:1965–69

    CrossRefPubMed
21. 21.↵
    1. Kamiryo T,
    2. Lopes MB,
    3. Kassell NF,
    4. et al

    . Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil. Neurosurgery 2001;49:409–14,discussion 414–15

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Bernstein M,
    2. Marotta T,
    3. Stewart P,
    4. et al

    . Brain damage from 125I brachytherapy evaluated by MR imaging, a blood-brain barrier tracer, and light and electron microscopy in a rat model. J Neurosurg 1990;73:585–93

    CrossRefPubMed
23. 23.↵
    1. Rubin P,
    2. Gash DM,
    3. Hansen JT,
    4. et al

    . Disruption of the blood-brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994;31:51–60

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Cao Y,
    2. Tsien CI,
    3. Sundgren PC,
    4. et al

    . Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin Cancer Res 2009;15:1747–54

    Abstract/FREE Full Text
25. 25.↵
    1. Lee MC,
    2. Cha S,
    3. Chang SM,
    4. et al

    . Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 2005;21:683–93

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Jain R,
    2. Ellika S,
    3. Lehman NL,
    4. et al

    . Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol 2010;97:383–88

    CrossRefPubMed
27. 27.↵
    1. Barajas RF,
    2. Chang JS,
    3. Sneed PK,
    4. et al

    . Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009;30:367–72

    Abstract/FREE Full Text
28. 28.↵
    1. Jain R,
    2. Gutierrez J,
    3. Narang J,
    4. et al

    . In vivo correlation of tumor blood volume and permeability with histological and molecular angiogenic markers in gliomas. AJNR Am J Neuroradiol 2011;32:388–94

    Abstract/FREE Full Text
29. 29.↵
    1. Nordal RA,
    2. Nagy A,
    3. Pintilie M,
    4. et al

    . Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 2004;10:3342–53

    Abstract/FREE Full Text
30. 30.↵
    1. Gonzalez J,
    2. Kumar AJ,
    3. Conrad CA,
    4. et al

    . Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007;67:323–26

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Torcuator R,
    2. Zuniga R,
    3. Mohan YS,
    4. et al

    . Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009;94:63–68

    CrossRefPubMed
32. 32.↵
    1. Gaensler EH,
    2. Dillon WP,
    3. Edwards MS,
    4. et al

    . Radiation-induced telangiectasia in the brain simulates cryptic vascular malformations at MR imaging. Radiology 1994;193:629–36

    PubMed